Identification of multiomics and immune infiltration-associated biomarkers for early gastric cancer: a machine learning-based diagnostic model development study
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: serum-proteomic candidates to immune infiltration and report a glmBoost+XGBoost four-protein model (mean AUC 0.792); tissue qRT-PCR/IHC and external expression cohorts provide bounded checks. The paper notes inconsistent B2M/CFL1 expression in one validation cohort, so early-detection utility remains exploratory.
Technology: glmBoost and XGBoost four-protein classifier
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- glmBoost and XGBoost four-protein classifier
- Limitation / still unknown
- The study reports evaluation in the stated cohort, samples, datasets, or engineering setting; performance and practical benefit beyond that evaluated setting remain unknown.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12885-025-14396-2 · https://doi.org/10.1186/s12885-025-14396-2 · https://pubmed.ncbi.nlm.nih.gov/40450287/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.